More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Further Patents for Cynata Unique Cymerus Technology

Sep 15, 2021 at 2:58 AM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · Sep 15, 2021 at 2:58 AM EDT

On 6ix: 6ix.com/news/further-patents-for-cynata-unique-cymerus-technology

Cynata Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cynata Therapeutics Limited on 6ix

Earlier from Cynata Therapeutics

  • Further Canadian Patent for CynataAug 30, 2021
  • Cynata Receives Notice of Allowance from US Patent OfficeAug 26, 2021
  • Ethics Approval for Cynatas Clinical Trial in DFUJun 30, 2021
  • Progress Toward Clinical Trial in Diabetic Foot UlcersJun 27, 2021
  • Cynata signs Licence Agreement with TekCyteJun 3, 2021

Later from Cynata Therapeutics

  • Cynata Enters into a New Strategic Partnership with FujifilmSep 30, 2021
  • DSMB Recommends Continuation of Cynatas MEND TrialOct 7, 2021
  • Cynata Receives US$5m Fujifilm FeeOct 17, 2021
  • Site Initiation Visit Completed for CYP DFU Clinical TrialNov 17, 2021
  • Cynata Commences DFU Clinical TrialDec 21, 2021
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer